Plus Therapeutics | CYTX - Net Income

Stock Price
0.30
Daily Change
-0.01 -4.21%
Monthly
13.89%
Yearly
-79.44%
Q1 Forecast
0.29

Plus Therapeutics reported $-4.8M in Net Income for its fiscal quarter ending in March of 2023.





Net Income Change Date
Baxter International USD -1.13B 1.08B Dec/2025
Cerus USD -20.92M 17.98M Dec/2024
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Northwest Biotherapeutics USD -19.37M 1.5M Sep/2024
Sanofi EUR -801M 3.6B Dec/2025
Starpharma Holdings AUD 1.37M 3.67M Dec/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025